• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高浓度C反应蛋白与低浓度五聚素3作为中心性浆液性脉络膜视网膜病变的生物标志物

High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.

作者信息

Bousquet Elodie, Chenevier-Gobeaux Camille, Jaworski Thara, Torres-Villaros Héloïse, Zola Marta, Mantel Irmela, Kowalczuk Laura, Matet Alexandre, Daruich Alejandra, Zhao Min, Yzer Suzanne, Behar-Cohen Francine

机构信息

Department of Ophthalmology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris Cité, Paris, France.

Centre de Recherche des Cordeliers, INSERM, University of Paris Cité, Physiopathology of ocular diseases: Therapeutic innovations, Paris, France.

出版信息

Ophthalmol Sci. 2023 Feb 3;3(3):100278. doi: 10.1016/j.xops.2023.100278. eCollection 2023 Sep.

DOI:10.1016/j.xops.2023.100278
PMID:36950301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10025279/
Abstract

PURPOSE

To investigate the association between the 2 acute phase proteins, C-reactive protein (CRP) and pentraxin 3 (PTX3) with central serous chorioretinopathy (CSCR), as PTX3 is a glucocorticoid-induced protein.

DESIGN

Cross-sectional multicenter study.

PARTICIPANTS

Patients with CSCR compared with age- and sex-matched healthy participants.

METHODS

Patients with CSCR from 3 centers in Europe were included in the study. The clinical form of CSCR was recorded. Blood samples from patients with CSCR and healthy participants were sampled, and high-sensitivity CRP and PTX3 levels were measured in the serum.

MAIN OUTCOME MEASURES

C-reactive protein and PTX3 serum level comparison between patients with CSCR with age- and sex-matched healthy participants.

RESULTS

Although CRP levels were higher in patients with CSCR (n = 216) than in age- and sex-matched controls (n = 130) (2.2 ± 3.2 mg/l vs. 1.5 mg/l ± 1.4, respectively,  = 0.037), PTX3 levels were lower in patients with CSCR (10.5 ± 19.9 pg/ml vs. 87.4 ± 73.2 pg/ml, respectively, < 0.001). There was no significant difference in CRP or PTX3 levels between patients with acute/recurrent and chronic CSCR.

CONCLUSIONS

In patients with CSCR, high CRP and low PTX3 levels suggest a form of low-grade systemic inflammation together with a lack of glucocorticoid pathway activation, raising new hypotheses on the pathophysiology of CSCR.

FINANCIAL DISCLOSURES

The author(s) have no proprietary or commercial interest in any materials discussed in this article.

摘要

目的

鉴于五聚素3(PTX3)是一种糖皮质激素诱导蛋白,研究两种急性期蛋白C反应蛋白(CRP)和五聚素3与中心性浆液性脉络膜视网膜病变(CSCR)之间的关联。

设计

横断面多中心研究。

参与者

将CSCR患者与年龄和性别匹配的健康参与者进行比较。

方法

纳入来自欧洲3个中心的CSCR患者。记录CSCR的临床类型。采集CSCR患者和健康参与者的血样,测定血清中的高敏CRP和PTX3水平。

主要观察指标

比较CSCR患者与年龄和性别匹配的健康参与者的C反应蛋白和PTX3血清水平。

结果

尽管CSCR患者(n = 216)的CRP水平高于年龄和性别匹配的对照组(n = 130)(分别为2.2±3.2mg/l和1.5mg/l±1.4,P = 0.037),但CSCR患者的PTX3水平较低(分别为10.5±19.9pg/ml和87.4±73.2pg/ml,P<0.001)。急性/复发性和慢性CSCR患者之间的CRP或PTX3水平无显著差异。

结论

在CSCR患者中,高CRP和低PTX3水平提示一种低度全身炎症形式以及糖皮质激素途径激活不足,这为CSCR的病理生理学提出了新的假设。

财务披露

作者对本文讨论的任何材料均无所有权或商业利益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936e/10025279/3cb3b320a251/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936e/10025279/c683a89090cd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936e/10025279/3cb3b320a251/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936e/10025279/c683a89090cd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936e/10025279/3cb3b320a251/gr2.jpg

相似文献

1
High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.高浓度C反应蛋白与低浓度五聚素3作为中心性浆液性脉络膜视网膜病变的生物标志物
Ophthalmol Sci. 2023 Feb 3;3(3):100278. doi: 10.1016/j.xops.2023.100278. eCollection 2023 Sep.
2
Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy.脂联素 2 作为中心性浆液性脉络膜视网膜病变的潜在系统生物标志物。
Sci Rep. 2020 Nov 19;10(1):20175. doi: 10.1038/s41598-020-77202-y.
3
Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中的中性粒细胞/淋巴细胞比值及平均血小板体积
Ther Clin Risk Manag. 2017 Jul 28;13:945-950. doi: 10.2147/TCRM.S138581. eCollection 2017.
4
Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria.循环 pentraxin-3 及其与慢性自发性荨麻疹患者 C 反应蛋白水平和疾病活动的关系。
Allergol Immunopathol (Madr). 2023 Jul 1;51(4):87-93. doi: 10.15586/aei.v51i4.894. eCollection 2023.
5
In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy.在患有特发性中心性浆液性脉络膜视网膜病变的患者中,焦虑评分高于健康对照组,但不随性别或复发性中心性浆液性脉络膜视网膜病变而变化。
Neuropsychiatr Dis Treat. 2015 Apr 28;11:1131-6. doi: 10.2147/NDT.S83216. eCollection 2015.
6
Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.急性和慢性中心性浆液性脉络膜视网膜病变中的黄斑神经节细胞复合体厚度
Int Ophthalmol. 2017 Apr;37(2):409-416. doi: 10.1007/s10792-016-0278-4. Epub 2016 Jun 20.
7
The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.纤溶酶原激活物抑制剂-1(PAI-1)基因4G/5G多态性在中心性浆液性脉络膜视网膜病变中的患病率及其与血浆PAI-1水平的关系。
Cutan Ocul Toxicol. 2014 Dec;33(4):270-4. doi: 10.3109/15569527.2013.854372. Epub 2014 Jan 22.
8
Plasma dopamine and catecholamine levels in patients with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者的血浆多巴胺和儿茶酚胺水平。
J Fr Ophtalmol. 2021 May;44(5):621-625. doi: 10.1016/j.jfo.2020.08.032. Epub 2021 Apr 15.
9
Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变病程中的神经节细胞丢失
Ophthalmol Ther. 2023 Feb;12(1):517-533. doi: 10.1007/s40123-022-00625-5. Epub 2022 Dec 12.
10
Prevalence of choroidal nevi in patients with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者脉络膜痣的患病率。
Ther Adv Ophthalmol. 2023 Jul 25;15:25158414231189080. doi: 10.1177/25158414231189080. eCollection 2023 Jan-Dec.

本文引用的文献

1
Corticotroph isolation from Pomc-eGFP mice reveals sustained transcriptional dysregulation characterising a mouse model of glucocorticoid-induced suppression of the hypothalamus-pituitary-adrenal axis.从 Pomc-eGFP 小鼠中分离促肾上腺皮质激素细胞揭示了持续的转录失调特征,这是一种糖皮质激素抑制下丘脑-垂体-肾上腺轴的小鼠模型。
J Neuroendocrinol. 2022 Jul;34(7):e13165. doi: 10.1111/jne.13165. Epub 2022 Jul 14.
2
IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms.白细胞介素 6 通过激活 STAT3 同工型调节 C 反应蛋白基因表达的诱导。
Mol Immunol. 2022 Jun;146:50-56. doi: 10.1016/j.molimm.2022.04.003. Epub 2022 Apr 14.
3
Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men.
女性与男性中心性浆液性脉络膜视网膜病变的临床特征及多模态影像学表现
J Clin Med. 2022 Mar 19;11(6):1706. doi: 10.3390/jcm11061706.
4
Elevated serum fibrinogen/albumin ratios in patients with acute central serous chorioretinopathy.急性中心性浆液性脉络膜视网膜病变患者血清纤维蛋白原/白蛋白比值升高。
Eur J Ophthalmol. 2022 May;32(3):1735-1742. doi: 10.1177/11206721221089773. Epub 2022 Mar 21.
5
Mineralocorticoid pathway in retinal health and diseases.视网膜健康与疾病中的盐皮质激素通路。
Br J Pharmacol. 2022 Jul;179(13):3190-3204. doi: 10.1111/bph.15770. Epub 2022 Jan 28.
6
Validation of central serous chorioretinopathy multimodal imaging-based classification system.基于多模态成像的中心性浆液性脉络膜视网膜病变分类系统的验证。
Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1161-1169. doi: 10.1007/s00417-021-05452-1. Epub 2021 Oct 20.
7
Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders.静脉超负荷性脉络膜病变:中心性浆液性脉络膜视网膜病变及相关疾病的一个假说框架
Prog Retin Eye Res. 2022 Jan;86:100973. doi: 10.1016/j.preteyeres.2021.100973. Epub 2021 May 21.
8
Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice.糖皮质激素撤药——临床实践中肾上腺皮质功能不全的诊断时机与方法概述
Diagnostics (Basel). 2021 Apr 20;11(4):728. doi: 10.3390/diagnostics11040728.
9
Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy.脂联素 2 作为中心性浆液性脉络膜视网膜病变的潜在系统生物标志物。
Sci Rep. 2020 Nov 19;10(1):20175. doi: 10.1038/s41598-020-77202-y.
10
How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression.不同生物活性的 C 反应蛋白结构异构体如何影响疾病进展。
Front Immunol. 2020 Sep 10;11:2126. doi: 10.3389/fimmu.2020.02126. eCollection 2020.